The Impact of Hyperlipidemia Management on Cardiovascular Risk Reduction: James Underberg, MD, MS, FACPM, FACP
Joining Dr. Gregg Sherman for this episode is Dr. James Underberg for a discussion about the impact of Hyperlipidemia management on Cardiovascular Risk Reduction.
Click here to access NACE on-demand CME/CE courses on cardiovascular disease
Dr. Underberg is a Clinical Assistant Professor of Medicine at NYU Medical School & NYU Center for CV Prevention, Director of the Bellevue Hospital Lipid Clinic and Past President of the National Lipid Association. We very excited to spend a few minutes with Dr. Underberg to discuss current clinical guidelines, his insights about the evolving state of lipid management, and the impact of Hyperlipidemia management on Cardiovascular Risk Reduction.
This activity is supported by educational funding provided by Amgen.
This activity is not certified for CME/CE credit.